Kurt‐Wolfram Sühs

3.5k total citations
77 papers, 1.6k citations indexed

About

Kurt‐Wolfram Sühs is a scholar working on Pathology and Forensic Medicine, Neurology and Epidemiology. According to data from OpenAlex, Kurt‐Wolfram Sühs has authored 77 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Pathology and Forensic Medicine, 26 papers in Neurology and 13 papers in Epidemiology. Recurrent topics in Kurt‐Wolfram Sühs's work include Multiple Sclerosis Research Studies (31 papers), Peripheral Neuropathies and Disorders (15 papers) and Autoimmune Neurological Disorders and Treatments (12 papers). Kurt‐Wolfram Sühs is often cited by papers focused on Multiple Sclerosis Research Studies (31 papers), Peripheral Neuropathies and Disorders (15 papers) and Autoimmune Neurological Disorders and Treatments (12 papers). Kurt‐Wolfram Sühs collaborates with scholars based in Germany, United States and Slovakia. Kurt‐Wolfram Sühs's co-authors include Thomas Skripuletz, Martin Stangel, Philipp Schwenkenbecher, Ulrich Wurster, Stefan Gingele, Refik Pul, Franz Felix Konen, Lena Bönig, Nora Möhn and Corinna Trebst and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Annals of Neurology.

In The Last Decade

Kurt‐Wolfram Sühs

73 papers receiving 1.6k citations

Peers

Countries citing papers authored by Kurt‐Wolfram Sühs

Since Specialization

Citations

This map shows the geographic impact of Kurt‐Wolfram Sühs's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kurt‐Wolfram Sühs with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kurt‐Wolfram Sühs more than expected).

Fields of papers citing papers by Kurt‐Wolfram Sühs

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kurt‐Wolfram Sühs. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kurt‐Wolfram Sühs. The network helps show where Kurt‐Wolfram Sühs may publish in the future.

Co-authorship network of co-authors of Kurt‐Wolfram Sühs

This figure shows the co-authorship network connecting the top 25 collaborators of Kurt‐Wolfram Sühs. A scholar is included among the top collaborators of Kurt‐Wolfram Sühs based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kurt‐Wolfram Sühs. Kurt‐Wolfram Sühs is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Switching from anti-CD20 therapies to cladribine and vice versa – Analysis of a German relapsing multiple sclerosis cohort 2025 ·Neurotherapeutics ·Franz Felix Konen, Steffen Pfeuffer, (unknown), Klaus Gehring, Birte Elias-Hamp, Kurt‐Wolfram Sühs, Stephan Halle, Korbinian Brand, Ralf Lichtinghagen, Eline A.J. Willemse, (unknown), Jens Kühle, (unknown), Christoph Kleinschnitz, Refik Pul, Thomas Skripuletz	0
2	Management of disease-modifying therapies in multiple sclerosis and comorbid rheumatoid arthritis 2025 ·Neurological Research and Practice ·Franz Felix Konen, Torsten Witte, Diana Ernst, David Hagin, Konstantin Fritz Jendretzky, Nora Möhn, Sandra Nay, Lea Grote‐Levi, Kurt‐Wolfram Sühs, Luisa Klotz, Steffen Pfeuffer, Refik Pul, Christoph Kleinschnitz, (unknown), (unknown), Thomas Skripuletz	0
3	The RESIST Senior Individuals Cohort: Design, participant characteristics and aims 2024 ·GeroScience ·Lennart M. Roesner, Manoj Kumar Gupta, Verena Kopfnagel, (unknown), Yvonne Kemmling, (unknown), (unknown), Xun Jiang, Lennart Riemann, Stephan Traidl, Berit Lange, Kurt‐Wolfram Sühs, Thomas Illig, Till Strowig, Yang Li, Reinhold Förster, Jochen Huehn, Thomas F. Schulz, Thomas Werfel, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	2
4	Ravulizumab in myasthenic crisis: the first case report 2024 ·Journal of Neurology ·Franz Felix Konen, Konstantin Fritz Jendretzky, (unknown), Ramona Schuppner, Kurt‐Wolfram Sühs, Marc Pawlitzki, Tobias Ruck, Sven G. Meuth, Thomas Skripuletz	6
5	Elevated phospholipids and acylcarnitines C4 and C5 in cerebrospinal fluid distinguish viral CNS infections from autoimmune neuroinflammation 2023 ·Journal of Translational Medicine ·(unknown), (unknown), (unknown), Frank Klawonn, Manas K. Akmatov, Kirsten Müller‐Vahl, Corinna Trebst, Thomas Skripuletz, Martin Stangel, Kurt‐Wolfram Sühs, Frank Peßler	10
6	Innovative therapeutic concepts of progressive multifocal leukoencephalopathy 2022 ·Journal of Neurology ·Nora Möhn, Lea Grote‐Levi, Franziska Hopfner, Britta Eiz‐Vesper, Britta Maecker‐Kolhoff, Clemens Warnke, Kurt‐Wolfram Sühs, Mike P. Wattjes, Günter U. Höglinger, Thomas Skripuletz	8
7	Kappa Free Light Chains in Cerebrospinal Fluid in Inflammatory and Non-Inflammatory Neurological Diseases 2022 ·Brain Sciences ·Franz Felix Konen, Philipp Schwenkenbecher, Konstantin Fritz Jendretzky, Stefan Gingele, Torsten Witte, Kurt‐Wolfram Sühs, Matthias Grothe, (unknown), Marie Süße, Thomas Skripuletz	13
8	The Influence of the Ventricular-Lumbar Gradient on Cerebrospinal Fluid Analysis in Serial Samples 2022 ·Brain Sciences ·Franz Felix Konen, Peter Lange, Ulrich Wurster, Konstantin Fritz Jendretzky, Stefan Gingele, Nora Möhn, Kurt‐Wolfram Sühs, Martin Stangel, Thomas Skripuletz, Philipp Schwenkenbecher	6
9	Diagnostic Cerebrospinal Fluid Biomarker in Early and Late Onset Multiple Sclerosis 2022 ·Biomedicines ·Franz Felix Konen, (unknown), Philipp Schwenkenbecher, Matthias Grothe, (unknown), Konstantin Fritz Jendretzky, Stefan Gingele, Kurt‐Wolfram Sühs, Torsten Witte, Thomas Skripuletz, Marie Süße	10
10	The Increasing Role of Kappa Free Light Chains in the Diagnosis of Multiple Sclerosis 2021 ·Cells ·Franz Felix Konen, Philipp Schwenkenbecher, Konstantin Fritz Jendretzky, Stefan Gingele, Kurt‐Wolfram Sühs, Hayrettin Tumani, Marie Süße, Thomas Skripuletz	21
11	PD-1-inhibitor pembrolizumab for treatment of progressive multifocal leukoencephalopathy 2021 ·Therapeutic Advances in Neurological Disorders ·Nora Möhn, Mike P. Wattjes, Ortwin Adams, Sandra Nay, (unknown), (unknown), (unknown), Kaweh Pars, Günter U. Höglinger, Gesine Respondek, Martin Stangel, Thomas Skripuletz, Roland Jacobs, Kurt‐Wolfram Sühs	12
12	Elevated Free Phosphatidylcholine Levels in Cerebrospinal Fluid Distinguish Bacterial from Viral CNS Infections 2021 ·Cells ·(unknown), Kurt‐Wolfram Sühs, Sven Schuchardt, (unknown), Kirsten Müller‐Vahl, Corinna Trebst, Thomas Skripuletz, Frank Klawonn, Martin Stangel, Frank Peßler	16
13	Intrathecal Antibody Production Against Epstein-Barr, Herpes Simplex, and Other Neurotropic Viruses in Autoimmune Encephalitis 2021 ·Neurology Neuroimmunology & Neuroinflammation ·Philipp Schwenkenbecher, Thomas Skripuletz, Peter Lange, (unknown), (unknown), Nora Möhn, Marius Ringelstein, Til Menge, Manuel A. Friese, Nico Melzer, Michael P. Malter, Martin Häusler, Franziska Thaler, Martin Stangel, Jan Lewerenz, Kurt‐Wolfram Sühs	20
14	Checkpoint inhibitor–induced autoimmune central nervous system disorder in patients with metastatic melanoma and Hodgkin’s lymphoma 2021 ·Clinical and Experimental Neuroimmunology ·Nora Möhn, Kurt‐Wolfram Sühs, (unknown), Martin Stangel, Philipp Ivanyi, Gernot Beutel, Ralf Gutzmer, Thomas Skripuletz, (unknown)	1
15	Evidence of Oligoclonal Bands Does Not Exclude Non-Inflammatory Neurological Diseases 2020 ·Diagnostics ·(unknown), Ulrich Wurster, Konstantin Fritz Jendretzky, Stefan Gingele, Kurt‐Wolfram Sühs, Martin Stangel, Thomas Skripuletz, Philipp Schwenkenbecher	25
16	Reiber’s Diagram for Kappa Free Light Chains: The New Standard for Assessing Intrathecal Synthesis? 2019 ·Diagnostics ·Philipp Schwenkenbecher, Franz Felix Konen, Ulrich Wurster, Torsten Witte, Stefan Gingele, Kurt‐Wolfram Sühs, Martin Stangel, Thomas Skripuletz	26
17	Ocrelizumab Depletes CD20+ T Cells in Multiple Sclerosis Patients 2018 ·Cells ·Stefan Gingele, (unknown), Franz Felix Konen, Martin W. Hümmert, Kurt‐Wolfram Sühs, Philipp Schwenkenbecher, Jonas Ahlbrecht, Nora Möhn, Lars Hendrik Müschen, Lena Bönig, Sascha Alvermann, Reinhold E. Schmidt, Martin Stangel, Roland Jacobs, Thomas Skripuletz	109
18	Clinically Isolated Syndrome According to McDonald 2010: Intrathecal IgG Synthesis Still Predictive for Conversion to Multiple Sclerosis 2017 ·International Journal of Molecular Sciences ·Philipp Schwenkenbecher, (unknown), Lena Bönig, Ulrich Wurster, Paul Bronzlik, Kurt‐Wolfram Sühs, Refik Pul, Martin Stangel, Thomas Skripuletz	23
19	McDonald Criteria 2010 and 2005 Compared: Persistence of High Oligoclonal Band Prevalence Despite Almost Doubled Diagnostic Sensitivity 2016 ·International Journal of Molecular Sciences ·Philipp Schwenkenbecher, (unknown), Ulrich Wurster, Paul Bronzlik, Kurt‐Wolfram Sühs, Peter Raab, Martin Stangel, Refik Pul, Thomas Skripuletz	33
20	Disease Activity and Conversion into Multiple Sclerosis after Optic Neuritis Is Treated with Erythropoietin 2016 ·International Journal of Molecular Sciences ·Kurt‐Wolfram Sühs, Panagiotis Papanagiotou, Katharina Hein, Refik Pul, (unknown), Christoph Heesen, Ricarda Diem	5

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact